Clinical Trial Update: A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the efficacy and safety of full-dose tenecteplase with either unfractionated heparin or enoxaparin in acute myocardial infarct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• Metalyse (tenecteplase)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED